Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases

Annals of Surgical Oncology

Volumn 20, Issue 8, 2013, Pages 2477-2484

  Correa Gallego, C ^a   Gonen, M ^a   Fischer, M ^a   Grant, F ^a   Kemeny, N E ^a   Arslan Carlon, V ^a   Kingham, T P ^a   Dematteo, R P ^a   Fong, Y ^a   Allen, P J ^a   D'Angelica, M I ^a   Jarnagin, W R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; FEMALE; HEMATOMA; HEMODILUTION; HUMAN; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; MORBIDITY; OVERALL SURVIVAL; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; RECURRENCE FREE SURVIVAL; SURGICAL MORTALITY;

ABDOMINAL ABSCESS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; EQUIPMENT FAILURE; FEMALE; HEMODILUTION; HEPATECTOMY; HOSPITAL MORTALITY; HUMANS; ILEUS; INFUSION PUMPS, IMPLANTABLE; LENGTH OF STAY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; NEOPLASM, RESIDUAL; RECURRENCE; RISK ASSESSMENT; SURGICAL WOUND INFECTION; SURVIVAL RATE; TACHYCARDIA; TIME FACTORS; VENOUS THROMBOSIS;

EID: 84880316255     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-2975-9     Document Type: Article

References (26)

1. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-18; discussion 318-21.
2. Blumberg N, Heal JM. Transfusion-induced immunomodulation and its possible role in cancer recurrence and perioperative bacterial infection. Yale J Biol Med. 1990;63:429-33.
3. Stephenson KR, Steinberg SM, Hughes KS, et al. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg. 1988;208:679-87.
4. Giuliante F, Ardito F, Vellone M, et al. Role of the surgeon as a variable in long-term survival after liver resection for colorectal metastases. J Surg Oncol. 2009;100:538-45.
5. Vigano L, Ferrero A, Lo Tesoriere R, et al. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol. 2008;15:2458-64.
6. Cunningham JD, Fong Y, Shriver C, et al. One hundred consecutive hepatic resections. Blood loss, transfusion, and operative technique. Arch Surg. 1994;129:1050-6.
7. Melendez J. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg. 1998;187:620-5.
8. Jarnagin WR, Gonen M, Maithel SK, et al. A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resection. Ann Surg. 2008;248:360-9.
9. House MG, Ito H, Gonen M, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg. 2010;210:744-52, 752-5.
10. Grobmyer SR, Pieracci FM, Allen PJ, et al. Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. J Am Coll Surg. 2007;204:356-64.
11. Farid SG, Aldouri A, Morris-Stiff G, et al. Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg. 2010;251:91-100.
12. Ito H, Are C, Gonen M, et al. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008;247:994-1002.
13. Chauhan A, House MG, Pitt HA, et al. Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma. HPB (Oxford). 2011;13:139-47.
14. Schiesser M, Chen JW, Maddern GJ, et al. Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases. J Gastrointest Surg. 2008;12:1054-60.
15. Tanaka K, Kumamoto T, Nojiri K, et al. Impact of postoperative morbidity on long-term survival after resection for colorectal liver metastases. Ann Surg Oncol. 2010. doi: 10.1245/s10434-010-1352-1
16. Kooby DA, Stockman J, Ben-Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg. 2003;237:860-9; discussion 869-70.
17. Mavros MN, de Jong M, Dogeas E, et al. Impact of complications on long-term survival after resection of colorectal liver metastases. Br J Surg. 2013;100(5):711-8.
18. Kobayashi T, Teruya M, Kishiki T, et al. Elevated C-reactive protein and hypoalbuminemia measured before resection of colorectal liver metastases predict postoperative survival. Dig Surg. 2010;27:285-90.
19. Wong VK, Malik HZ, Hamady ZZ, et al. C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer. 2007;96:222-5.
20. Martinez-Salamanca JI, Shariat SF, Rodriguez JC, et al. Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int. 2011;109(8):1155-61.
21. Wedding U, Rohrig B, Klippstein A, et al. Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol. 2007;133:945-50.
22. Foster JH, Berman MM: Solid liver tumors. Major Probl Clin Surg. 1977;22:1-342.
23. Virani S, Michaelson JS, Hutter MM, et al. Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg. 2007;204:1284-92.
24. Kamiyama T, Nakanishi K, Yokoo H, et al. Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution. J Am Coll Surg. 2010;211:443-9.
25. Fan ST, Mau Lo C, Poon RT, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg. 2011;253:745-58.
26. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236:397-406; discussion 406-7.